BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 33974994)

  • 21. Baseline Features and Reasons for Nonparticipation in the Colonoscopy Versus Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer (CONFIRM) Study, a Colorectal Cancer Screening Trial.
    Robertson DJ; Dominitz JA; Beed A; Boardman KD; Del Curto BJ; Guarino PD; Imperiale TF; LaCasse A; Larson MF; Gupta S; Lieberman D; Planeta B; Shaukat A; Sultan S; Menees SB; Saini SD; Schoenfeld P; Goebel S; von Rosenvinge EC; Baffy G; Halasz I; Pedrosa MC; Kahng LS; Cassim R; Greer KB; Kinnard MF; Bhatt DB; Dunbar KB; Harford WV; Mengshol JA; Olson JE; Patel SG; Antaki F; Fisher DA; Sullivan BA; Lenza C; Prajapati DN; Wong H; Beyth R; Lieb JG; Manlolo J; Ona FV; Cole RA; Khalaf N; Kahi CJ; Kohli DR; Rai T; Sharma P; Anastasiou J; Hagedorn C; Fernando RS; Jackson CS; Jamal MM; Lee RH; Merchant F; May FP; Pisegna JR; Omer E; Parajuli D; Said A; Nguyen TD; Tombazzi CR; Feldman PA; Jacob L; Koppelman RN; Lehenbauer KP; Desai DS; Madhoun MF; Tierney WM; Ho MQ; Hockman HJ; Lopez C; Carter Paulson E; Tobi M; Pinillos HL; Young M; Ho NC; Mascarenhas R; Promrat K; Mutha PR; Pandak WM; Shah T; Schubert M; Pancotto FS; Gawron AJ; Underwood AE; Ho SB; Magno-Pagatzaurtundua P; Toro DH; Beymer CH; Kaz AM; Elwing J; Gill JA; Goldsmith SF; Yao MD; Protiva P; Pohl H; Kyriakides T;
    JAMA Netw Open; 2023 Jul; 6(7):e2321730. PubMed ID: 37432690
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of screening using annual fecal immunochemical test alone versus combined with one-time colonoscopy in reducing colorectal cancer mortality: the Akita Japan population-based colonoscopy screening trial (Akita pop-colon trial).
    Saito H; Kudo SE; Takahashi N; Yamamoto S; Kodama K; Nagata K; Mizota Y; Ishida F; Ohashi Y
    Int J Colorectal Dis; 2020 May; 35(5):933-939. PubMed ID: 32034490
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Lin JS; Piper MA; Perdue LA; Rutter CM; Webber EM; O'Connor E; Smith N; Whitlock EP
    JAMA; 2016 Jun; 315(23):2576-94. PubMed ID: 27305422
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of Sex, Age, and Positivity Threshold on Fecal Immunochemical Test Accuracy: A Systematic Review and Meta-analysis.
    Selby K; Levine EH; Doan C; Gies A; Brenner H; Quesenberry C; Lee JK; Corley DA
    Gastroenterology; 2019 Dec; 157(6):1494-1505. PubMed ID: 31472152
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A delay in the diagnosis of colorectal cancer screened by fecal immunochemical tests during the COVID-19 pandemic: a longitudinal cohort study.
    Ishibashi F; Shida D; Suzuki S; Nagai M; Mochida K; Morishita T
    Int J Colorectal Dis; 2022 Dec; 37(12):2543-2546. PubMed ID: 36383225
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Colorectal Cancer Screening With Traditional and New-generation Fecal Immunochemical Tests: A Critical Review of Fecal Occult Blood Tests.
    Meklin J; Syrjänen K; Eskelinen M
    Anticancer Res; 2020 Feb; 40(2):575-581. PubMed ID: 32014898
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative evaluation of immunochemical fecal occult blood tests for colorectal adenoma detection.
    Hundt S; Haug U; Brenner H
    Ann Intern Med; 2009 Feb; 150(3):162-9. PubMed ID: 19189905
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk of colorectal cancer in patients with positive results of fecal immunochemical test performed within 5 years since the last colonoscopy.
    Jung YS; Lee J; Moon CM
    Korean J Intern Med; 2021 Sep; 36(5):1083-1091. PubMed ID: 34134468
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening for Colorectal Cancer With Fecal Immunochemical Testing With and Without Postpolypectomy Surveillance Colonoscopy: A Cost-Effectiveness Analysis.
    Greuter MJE; de Klerk CM; Meijer GA; Dekker E; Coupé VMH
    Ann Intern Med; 2017 Oct; 167(8):544-554. PubMed ID: 28973514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Diagnostic performance of quantitative fecal immunochemical test in detection of advanced colorectal neoplasia].
    Lu M; Chen HD; Liu CC; Zhang YH; Wei LP; Lyu ZY; Ren JS; Shi JF; Zou SM; Li N; Dai M
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Dec; 41(12):2104-2111. PubMed ID: 33378824
    [No Abstract]   [Full Text] [Related]  

  • 31. Fecal immunochemical test in colorectal cancer screening: Colonoscopy findings by different cut-off levels.
    Ribbing Wilén H; Blom J; Höijer J; Hultcrantz R
    J Gastroenterol Hepatol; 2019 Jan; 34(1):103-112. PubMed ID: 29968937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fresh vs Frozen Samples and Ambient Temperature Have Little Effect on Detection of Colorectal Cancer or Adenomas by a Fecal Immunochemical Test in a Colorectal Cancer Screening Cohort in Germany.
    Chen H; Werner S; Brenner H
    Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1547-1556.e5. PubMed ID: 27793749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Lin JS; Perdue LA; Henrikson NB; Bean SI; Blasi PR
    JAMA; 2021 May; 325(19):1978-1998. PubMed ID: 34003220
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Performance Characteristics of Fecal Immunochemical Tests for Colorectal Cancer and Advanced Adenomatous Polyps: A Systematic Review and Meta-analysis.
    Imperiale TF; Gruber RN; Stump TE; Emmett TW; Monahan PO
    Ann Intern Med; 2019 Mar; 170(5):319-329. PubMed ID: 30802902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer.
    Dinh T; Ladabaum U; Alperin P; Caldwell C; Smith R; Levin TR
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1158-66. PubMed ID: 23542330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term performance of colorectal cancerscreening programmes based on the faecal immunochemical test.
    Zorzi M; Hassan C; Capodaglio G; Fedato C; Montaguti A; Turrin A; Rosano A; Monetti D; Stocco C; Baracco S; Russo F; Repici A; Rugge M
    Gut; 2018 Dec; 67(12):2124-2130. PubMed ID: 29101260
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Faecal immunochemical tests to triage patients with lower abdominal symptoms for suspected colorectal cancer referrals in primary care: a systematic review and cost-effectiveness analysis.
    Westwood M; Corro Ramos I; Lang S; Luyendijk M; Zaim R; Stirk L; Al M; Armstrong N; Kleijnen J
    Health Technol Assess; 2017 May; 21(33):1-234. PubMed ID: 28643629
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Colorectal Cancer Screening: Recommendations for Physicians and Patients From the U.S. Multi-Society Task Force on Colorectal Cancer.
    Rex DK; Boland CR; Dominitz JA; Giardiello FM; Johnson DA; Kaltenbach T; Levin TR; Lieberman D; Robertson DJ
    Gastroenterology; 2017 Jul; 153(1):307-323. PubMed ID: 28600072
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Comparison of Fecal Immunochemical and High-Sensitivity Guaiac Tests for Colorectal Cancer Screening.
    Shapiro JA; Bobo JK; Church TR; Rex DK; Chovnick G; Thompson TD; Zauber AG; Lieberman D; Levin TR; Joseph DA; Nadel MR
    Am J Gastroenterol; 2017 Nov; 112(11):1728-1735. PubMed ID: 29016558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Test characteristics of faecal immunochemical tests (FIT) compared with optical colonoscopy.
    Levy BT; Bay C; Xu Y; Daly JM; Bergus G; Dunkelberg J; Moss C
    J Med Screen; 2014 Sep; 21(3):133-43. PubMed ID: 24958730
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.